BARCLAYS PLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$35,664
+5.1%
1,314,079
+19.1%
0.02%
+4.8%
Q2 2023$33,928
+117.3%
1,103,665
+154.6%
0.02%
+200.0%
Q1 2023$15,617
-1.8%
433,461
+7.8%
0.01%0.0%
Q4 2022$15,896
-99.8%
402,190
+82.2%
0.01%
-30.0%
Q3 2022$8,868,000
+0.1%
220,693
+4.7%
0.01%
+100.0%
Q2 2022$8,862,000
+22.6%
210,779
+13.6%
0.01%
-16.7%
Q1 2022$7,231,000185,5600.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders